Funding for this research was provided by:
AstraZeneca Pharmaceutical Co. Ltd
Article History
Accepted: 29 March 2022
First Online: 28 April 2022
Declarations
:
: This study was funded by AstraZeneca Pharmaceutical Co. Ltd (Beijing, China).
: Jia Liu, Xiaoning He, and Jing Wu declare they have no conflicts of interest.
: Not applicable.
: Not applicable.
: All data generated or analyzed during this study are included in this published article and its supplementary information files.
: The model used in this study was provided to the journal’s peer reviewers for their reference when reviewing the manuscript. The Microsoft Excel simulation model used for the analysis is available from the corresponding author upon reasonable request.
: Concept and design: JL, XH, and JW. Acquisition of data: JL, XH, and JW. Development of decision analytical model: JL, XH, and JW. Analysis of data: JL. All authors participated in critically reviewing and interpreting the data, critically reviewed the manuscript for intellectual content, and approved the final version for publication submission. All authors agree to be accountable for all aspects of this work.